Clinical Trial

Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated November 22, 2023 (before its estimated December 2024 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to To confirm the predictive value of CCND1 for TPF induction in cN2 patients with OSCC
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2014-11-08; most recent amendment 2023-11-21.
Status change: Not Yet Recruiting → Recruiting 2017-08-16
Trial Details
NCT Number NCT02290145
Lead Sponsor Shanghai Jiao Tong University School of Medicine
Conditions Mouth Neoplasms, Carcinoma, Squamous Cell
Enrollment 48 participants
Start Date 2016-12
Primary Completion 2024-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2023-11-22